Trial Profile
A phase IIIa clinical trial of an autologous cancer vaccine (OncoVAX) in stage II or III colon cancer patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2017
Price :
$35
*
At a glance
- Drugs Autologous-cancer vaccine-Vaccinogen (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Sep 2017 New trial record.